SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-315411
Filing Date
2017-10-20
Accepted
2017-10-20 16:30:56
Documents
6
Period of Report
2017-12-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A d460369dpre14a.htm PRE 14A 566593
2 GRAPHIC g460369g39r78.jpg GRAPHIC 27791
3 GRAPHIC g460369g54o15.jpg GRAPHIC 23639
4 GRAPHIC g460369g58n43.jpg GRAPHIC 8319
5 GRAPHIC g460369g64d68.jpg GRAPHIC 12703
6 GRAPHIC g460369g71i24.jpg GRAPHIC 28207
  Complete submission text file 0001193125-17-315411.txt   706730
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31791 | Film No.: 171147285
SIC: 2834 Pharmaceutical Preparations